Bjerre, M.T.; Strand, S.H.; Nørgaard, M.; Kristensen, H.; Rasmussen, A.K.; Mortensen, M.M.; Fredsøe, J.; Mouritzen, P.; Ulhøi, B.; Ørntoft, T.;
et al. Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer. Int. J. Mol. Sci. 2019, 20, 1173.
https://doi.org/10.3390/ijms20051173
AMA Style
Bjerre MT, Strand SH, Nørgaard M, Kristensen H, Rasmussen AK, Mortensen MM, Fredsøe J, Mouritzen P, Ulhøi B, Ørntoft T,
et al. Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer. International Journal of Molecular Sciences. 2019; 20(5):1173.
https://doi.org/10.3390/ijms20051173
Chicago/Turabian Style
Bjerre, Marianne T., Siri H. Strand, Maibritt Nørgaard, Helle Kristensen, Anne KI Rasmussen, Martin Mørck Mortensen, Jacob Fredsøe, Peter Mouritzen, Benedicte Ulhøi, Torben Ørntoft,
and et al. 2019. "Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer" International Journal of Molecular Sciences 20, no. 5: 1173.
https://doi.org/10.3390/ijms20051173
APA Style
Bjerre, M. T., Strand, S. H., Nørgaard, M., Kristensen, H., Rasmussen, A. K., Mortensen, M. M., Fredsøe, J., Mouritzen, P., Ulhøi, B., Ørntoft, T., Borre, M., & Sørensen, K. D.
(2019). Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer. International Journal of Molecular Sciences, 20(5), 1173.
https://doi.org/10.3390/ijms20051173